Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions

Nasal upregulation of CST1 in dog sensitised children with severe allergic airway disease

Ulrika Käck, Elisabet Einarsdottir, Marianne van Hage, Anna Asarnoj, Anna James, Anna Nopp, Kaarel Krjutskov, Shintaro Katayama, Juha Kere, Gunnar Lilja, Cilla Söderhäll, Jon R. Konradsen
ERJ Open Research 2021; DOI: 10.1183/23120541.00917-2020
Ulrika Käck
1Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden
2Sachś Childrens and Youth Hospital, Södersjukhuset, Stockholm, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabet Einarsdottir
3Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
4Science for Life Laboratory, Department of Gene Technology, KTH-Royal Institute of Technology, Solna, Sweden
5Folkhälsan Research Center, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marianne van Hage
6Department of Medicine Solna, Division of Immunology and Allergy, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Asarnoj
7Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden
8Department of Womeńs and Children's Health, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna James
9Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Nopp
1Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden
2Sachś Childrens and Youth Hospital, Södersjukhuset, Stockholm, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaarel Krjutskov
3Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
10Department of Obstetrics and Gynecology, University of Tartu, Tartu, Estonia
11Competence Centre on Health Technologies, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shintaro Katayama
3Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
5Folkhälsan Research Center, Helsinki, Finland
12University of Helsinki, Stem Cells and Metabolism Research Program, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shintaro Katayama
Juha Kere
3Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
13Folkhälsan Research Institute, and Stem Cell and Metabolism Research Program, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gunnar Lilja
1Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden
2Sachś Childrens and Youth Hospital, Södersjukhuset, Stockholm, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cilla Söderhäll
3Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
7Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden
8Department of Womeńs and Children's Health, Karolinska Institutet, Stockholm, Sweden
14shared last authorship
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cilla Söderhäll
  • For correspondence: cilla.soderhall@ki.se
Jon R. Konradsen
7Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden
8Department of Womeńs and Children's Health, Karolinska Institutet, Stockholm, Sweden
14shared last authorship
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background The clinical presentation of children sensitised to dog dander varies from asymptomatic to severe allergic airway disease, but the genetic mechanisms underlying these differences are not clear.

Objective To investigate nasal transcriptomic profiles associated with dog dander sensitisation in school children and to reveal clinical symptoms related with these profiles.

Methods RNA was extracted from nasal epithelial cell brushings of children sensitised to dog dander and healthy controls. Blood sample analyses included IgE against dog dander, dog allergen molecules, other airborne and food allergens, basophil activation and white blood cell counts. Clinical history of asthma and rhinitis was recorded, and lung function was assessed (spirometry, methacholine provocation and FeNO).

Results The most over-expressed gene in children sensitised to dog dander compared to healthy controls was CST1, coding for Cystatin 1. A cluster of these children with enhanced CST1 expression showed lower FEV1, increased bronchial hyper-reactivity, pronounced eosinophilia and higher basophil allergen threshold sensitivity compared with other children sensitised to dog dander. Multi-sensitisation to lipocalins was also more common in this group.

Conclusions Over-expression of CST1 is associated with more severe allergic airway disease in children sensitised to dog dander. CST1 is thus a possible biomarker of the severity of allergic airway disease and a possible therapeutic target for the future treatment of airborne allergy.

Footnotes

This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.

Conflict of interest: U. Käck reports a lecture fee from Thermo Fisher outside the submitted work.

Conflict of interest: Dr. Einarsdottir has nothing to disclose.

Conflict of interest: M. van Hage reports lecture fees from Thermo Fisher Scientific and ALK, and consultancy fees from Biomay AG, Vienna, Austria and Hycor Biomedical LLC, CA, US, outside the submitted work.

Conflict of interest: Dr. Asarnoj has nothing to disclose.

Conflict of interest: Dr. James has nothing to disclose.

Conflict of interest: Dr. Nopp has nothing to disclose.

Conflict of interest: Dr. Krjutškov has nothing to disclose.

Conflict of interest: Dr. Katayama reports grants from Jane and Aatos Erkko Foundation, during the conduct of the study.

Conflict of interest: Dr. Kere has nothing to disclose.

Conflict of interest: Dr. Lilja has nothing to disclose.

Conflict of interest: Dr. Söderhäll has nothing to disclose.

Conflict of interest: Dr. Konradsen has received material from Thermo Fishes Scientific to perform IgE analysis in this project.

This is a PDF-only article. Please click on the PDF link above to read it.

  • Received December 7, 2020.
  • Accepted January 27, 2021.
  • ©The authors 2021
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org

PreviousNext
Back to top
Vol 7 Issue 1 Table of Contents
ERJ Open Research: 7 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nasal upregulation of CST1 in dog sensitised children with severe allergic airway disease
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Nasal upregulation of CST1 in dog sensitised children with severe allergic airway disease
Ulrika Käck, Elisabet Einarsdottir, Marianne van Hage, Anna Asarnoj, Anna James, Anna Nopp, Kaarel Krjutskov, Shintaro Katayama, Juha Kere, Gunnar Lilja, Cilla Söderhäll, Jon R. Konradsen
ERJ Open Research Jan 2021, 00917-2020; DOI: 10.1183/23120541.00917-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Nasal upregulation of CST1 in dog sensitised children with severe allergic airway disease
Ulrika Käck, Elisabet Einarsdottir, Marianne van Hage, Anna Asarnoj, Anna James, Anna Nopp, Kaarel Krjutskov, Shintaro Katayama, Juha Kere, Gunnar Lilja, Cilla Söderhäll, Jon R. Konradsen
ERJ Open Research Jan 2021, 00917-2020; DOI: 10.1183/23120541.00917-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Microbial and clinical factors are related to recurrence of symptoms after childhood lower respiratory tract infection
  • Chest computed tomography and alveolar-arterial oxygen gradient as rapid tools to diagnose and triage mildly symptomatic COVID-19 pneumonia patients
  • Anti-HSP47 siRNA Lipid Nanoparticle ND-L02-s0201 Reverses Interstitial Pulmonary Fibrosis in Preclinical Rat Models
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2021 by the European Respiratory Society